Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis

AD Shkodina, M Bardhan, H Chopra, OE Anyagwa… - CNS drugs, 2024 - Springer
Multiple sclerosis is a chronic inflammatory disease that affects the central nervous system
and can cause various types of pain including ongoing extremity pain, Lhermitte's …

Managing neuropathic pain in multiple sclerosis: pharmacological interventions

SS Duffy, JG Lees, CJ Perera… - Medicinal …, 2018 - ingentaconnect.com
Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the
central nervous system (CNS). Of the plethora of motor and sensory disturbances …

Neuropathic pain in multiple sclerosis–current therapeutic intervention and future treatment perspectives

KL Murphy, JR Bethea, R Fischer - Exon Publications, 2017 - exonpublications.com
Chronic pain is defined as any consistent pain lasting more than 12 weeks; chronic pain
afflicts 25% of the world's population. The most common form of chronic pain is chronic …

Pharmacotherapeutic options for managing pain in multiple sclerosis

G Di Stefano, G De Stefano, A Di Lionardo, G Cruccu… - CNS drugs, 2020 - Springer
Pain is a major matter for patients with multiple sclerosis; treatment response is frequently
inadequate, with a significant impact on quality of life. The estimated prevalence of pain in …

Pharmacological management of pain in patients with multiple sclerosis

C Solaro, MM Uccelli - Drugs, 2010 - Springer
Multiple sclerosis (MS) is an inflammatory, demyelinating, autoimmune disease of the CNS.
There are currently a number of disease-modifying medications for MS that modulate or …

An update on the pharmacological management of pain in patients with multiple sclerosis

CG Chisari, E Sgarlata, S Arena… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The prevalence of pain in Multiple Sclerosis (MS) is estimated to be between 29-
86% depending on various stages of the disease. According to a recent mechanism-based …

Pharmacological treatment of pain in multiple sclerosis

C Solaro, P Tanganelli… - Expert Review of …, 2007 - Taylor & Francis
Pain is a common symptom in multiple sclerosis (MS) and was recently estimated to be
experienced by up to 75% of patients. Nociceptive and neuropathic pain in MS may be …

Advances in the understanding and management of chronic pain in multiple sclerosis: a comprehensive review

I Urits, L Adamian, J Fiocchi, D Hoyt, C Ernst… - Current pain and …, 2019 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is an autoimmune disorder of the central
nervous system that can lead to severe physical, cognitive, and neurological deficits that …

Management of pain in multiple sclerosis: a pharmacological approach

C Solaro, M Messmer Uccelli - Nature Reviews Neurology, 2011 - nature.com
About half of patients with multiple sclerosis (MS) report pain; treatment for pain alone
accounts for nearly 30% of the total use of medications for the management of all MS-related …

A systematic review of pharmacological pain management in multiple sclerosis

R Jawahar, U Oh, S Yang, KL Lapane - Drugs, 2013 - Springer
Background Both chronic and acute pain have been cited as the most common symptoms
amongst patients with multiple sclerosis (MS), with recent prevalence estimates as high as …